The original success of the copyright undeniably reshaped the medication landscape, but betting in companies strongly reliant on off-patent versions presents a uncertain picture. Despite early earnings were significant, the end of patents and the appearance of cheaper alternatives have diminished market share. Therefore, a thorough assessment of cu